The tumor macroenvironment and systemic regulation of breast cancer progression

International Journal of Developmental Biology

Volumn 55, Issue 7-9, 2011, Pages 889-897

  Castaño, Zafira ^a   Tracy, Kristin ^a   McAllister, Sandra S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Dormancy; Metastasis; Microenvironment; Systemic instigation

Indexed keywords

ATAXIN 1; CD45 ANTIGEN; COLONY STIMULATING FACTOR 1; EPIDERMAL GROWTH FACTOR; OSTEOPONTIN; STEM CELL FACTOR;

B LYMPHOCYTE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CANCER RESEARCH; CANCER STAGING; CELL TRANSFORMATION; HUMAN; MACROPHAGE; METASTASIS POTENTIAL; MOLECULAR MECHANICS; NONHUMAN; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MICE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT;

EID: 82555181271     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.113366zc     Document Type: Review

References (117)

1. AGUIRRE GHISO, J.A., KOVALSKI, K. and OSSOWSKI, L. (1999). Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147: 89-104.
2. AGUIRRE-GHISO, J.A. (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834-846.
3. AGUIRRE-GHISO, J.A., ESTRADA, Y., LIU, D. and OSSOWSKI, L. (2003). ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 63: 1684-1695.
4. AGUIRRE-GHISO, J.A., LIU, D., MIGNATTI, A., KOVALSKI, K. and OSSOWSKI, L. (2001). Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 12: 863-879.
5. AHARINEJAD, S., PAULUS, P., SIOUD, M., HOFMANN, M., ZINS, K., SCHAFER, R., STANLEY, E.R. and ABRAHAM, D. (2004). Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res 64: 5378-8534.
6. AL-HAJJ, M., WICHA, M.S., BENITO-HERNANDEZ, A., MORRISON, S.J. and CLARKE, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
7. ALMOG, N. (2010). Molecular mechanisms underlying tumor dormancy. Cancer Lett 294: 139-146.
8. ALMOG, N., HENKE, V., FLORES, L., HLATKY, L., KUNG, A.L., WRIGHT, R.D., BERGER, R., HUTCHINSON, L., NAUMOV, G.N., BENDER, E. et al., (2006). Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis. FASEB J 20: 947-949.
9. ANDREU, P., JOHANSSON, M., AFFARA, N.I., PUCCI, F., TAN, T., JUNANKAR, S., KORETS, L., LAM, J., TAWFIK, D., DENARDO, D.G. et al., (2010). FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 17: 121-134.
10. BALKWILL, F. and MANTOVANI, A. (2001). Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
11. BATEMAN, A. and BENNETT, H.P. (2009). The granulin gene family: from cancer to dementia. Bioessays 31: 1245-1254.
12. BEHBOD, F., KITTRELL, F.S., LAMARCA, H., EDWARDS, D., KERBAWY, S., HEESTAND, J.C., YOUNG, E., MUKHOPADHYAY, P., YEH, H.W., ALLRED, D.C. et al., (2009). An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res 11: R66.
13. BISSELL, M.J. and RADISKY, D. (2001). Putting tumours in context. Nat Rev Cancer 1: 46-54.
14. BLACK, W.C. and WELCH, H.G. (1993). Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 328: 1237-1243.
15. BOS, P.D., ZHANG, X.H., NADAL, C., SHU, W., GOMIS, R.R., NGUYEN, D.X., MINN, A.J., VAN DE VIJVER, M.J., GERALD, W.L., FOEKENS, J.A. et al., (2009). Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009.
16. BOWERS, R.F. and YOUNG, J.M. (1960). Carcinoma arising in scars, osteomyelitis, and fistulae. Arch Surg 80: 564-570.
17. BUBACK, F., RENKL, A.C., SCHULZ, G. and WEISS, J.M. (2009). Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp Dermatol 18: 750-759.
18. CAMP, J.T., ELLOUMI, F., ROMAN-PEREZ, E., REIN, J., STEWART, D.A., HARRELL, J.C., PEROU, C.M. and TROESTER, M.A. (2011). Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers. Mol Cancer Res 9: 3-13.
19. CARMICHAEL, A.R., BENDALL, S., LOCKERBIE, L., PRESCOTT, R. and BATES, T. (2002). The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. Eur J Surg Oncol 28: 388-391.
20. CHANG, W.L., YANG, H.B., CHENG, H.C., CHUANG, C.H., LU, P.J. and SHEU, B.S. (2011). Increased Gastric Osteopontin Expression by Helicobacter pylori Infection can Correlate with More Severe Gastric Inflammation and Intestinal Metaplasia. Helicobacter 16: 217-224.
21. CLARKE, R. (1996). Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. Breast Cancer Res Treat 39: 69-86.
22. COFFEY, J.C., WANG, J.H., SMITH, M.J., BOUCHIER-HAYES, D., COTTER, T.G. and REDMOND, H.P. (2003). Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol 4: 760-768.
23. DE VISSER, K.E., KORETS, L.V. and COUSSENS, L.M. (2005). De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7: 411-423.
24. DEMICHELI, R., RETSKY, M.W., HRUSHESKY, W.J. and BAUM, M. (2007). Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures. Nat Clin Pract Oncol 4: 699-710.
25. DEMICHELI, R., TERENZIANI, M., VALAGUSSA, P., MOLITERNI, A., ZAMBETTI, M. and BONADONNA, G. (1994). Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 86: 45-48.
26. DENARDO, D.G., ANDREU, P. and COUSSENS, L.M. (2010). Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity. Cancer Metastasis Rev 29: 309-316.
27. DENARDO, D.G., BARRETO, J.B., ANDREU, P., VASQUEZ, L., TAWFIK, D., KOLHATKAR, N. and COUSSENS, L.M. (2009). CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16: 91-102.
28. DENARDO, D.G., BRENNAN, D.J., REXHEPAJ, E., RUFFELL, B., SHIAO, S.L., MADDEN, S.F., GALLAGHER, W.M., WADHWANI, N., KEIL, S.D., JUNAID, S.A. et al., (2011). Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy. Cancer Discovery 1: 54-67.
29. DING, L., ELLIS, M.J., LI, S., LARSON, D.E., CHEN, K., WALLIS, J.W., HARRIS, C.C., MCLELLAN, M.D., FULTON, R.S., FULTON, L.L. et al., (2010). Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999-1005.
30. DOLBERG, D.S., HOLLINGSWORTH, R., HERTLE, M. and BISSELL, M.J. (1985). Wounding and its role in RSV-mediated tumor formation. Science 230: 676-678.
31. ELKABETS, M., GIFFORD, A.M., SCHEEL, C., NILSSON, B., REINHARDT, F., BRAY, M.A., CARPENTER, A.E., JIRSTROM, K., MAGNUSSON, K., EBERT, B.L. et al., (2011). Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest 121: 784-799.
32. EREZ, N., TRUITT, M., OLSON, P., ARRON, S.T. and HANAHAN, D. (2010). Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell 17: 135-147.
33. EYLES, J., PUAUX, A.L., WANG, X., TOH, B., PRAKASH, C., HONG, M., TAN, T.G., ZHENG, L., ONG, L.C., JIN, Y. et al., (2010). Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 120: 2030-2039.
34. FEHM, T., MUELLER, V., MARCHES, R., KLEIN, G., GUECKEL, B., NEUBAUER, H., SOLOMAYER, E. and BECKER, S. (2008). Tumor cell dormancy: implications for the biology and treatment of breast cancer. APMIS 116: 742-753.
35. FLEMING, J.M., MILLER, T.C., QUINONES, M., XIAO, Z., XU, X., MEYER, M.J., GINSBURG, E., VEENSTRA, T.D. and VONDERHAAR, B.K. (2010). The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo. BMC Med 8: 27.
36. FLOOK, D., HORGAN, K., TAYLOR, B.A. and HUGHES, L.E. (1986). Surgery for malignant melanoma: from which limb should the graft be taken? Br J Surg 73: 793-795.
37. FOLKMAN, J. and KALLURI, R. (2004). Cancer without disease. Nature 427: 787.
38. GAMATSI, I.E., MCCULLOCH, T.A., BAILIE, F.B. and SRINIVASAN, J.R. (2000). Malignant melanoma in a skin graft: burn scar neoplasm or a transferred melanoma? Br J Plast Surg 53: 342-344.
39. GILL, M., DIAS, S., HATTORI, K., RIVERA, M.L., HICKLIN, D., WITTE, L., GIRARDI, L., YURT, R., HIMEL, H. and RAFII, S. (2001). Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88: 167-174.
40. GOHONGI, T., FUKUMURA, D., BOUCHER, Y., YUN, C.O., SOFF, G.A., COMPTON, C., TODOROKI, T. and JAIN, R.K. (1999). Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1. Nat Med 5: 1203-8.
41. GREENBERG, P.A., HORTOBAGYI, G.N., SMITH, T.L., ZIEGLER, L.D., FRYE, D.K. and BUZDAR, A.U. (1996). Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14: 2197-205.
42. HADFIELD, G. (1954). The dormant cancer cell. Br Med J 2: 607-610.
43. HARACH, H.R., FRANSSILA, K.O. and WASENIUS, V.M. (1985). Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 56: 531-538.
44. HARMAN, B.C., NORTHRUP, D.L. and ALLMAN, D. (2008). Resolution of unique Sca-1highc-Kit-lymphoid-biased progenitors in adult bone marrow. J Immunol 181: 7514-7524.
45. HE, Z., ONG, C.H., HALPER, J. and BATEMAN, A. (2003). Progranulin is a mediator of the wound response. Nat Med 9: 225-229.
46. HEISSIG, B., HATTORI, K., DIAS, S., FRIEDRICH, M., FERRIS, B., HACKETT, N.R., CRYSTAL, R.G., BESMER, P., LYDEN, D., MOORE, M.A. et al., (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
47. HIRATSUKA, S., NAKAMURA, K., IWAI, S., MURAKAMI, M., ITOH, T., KIJIMA, H., SHIPLEY, J.M., SENIOR, R.M. and SHIBUYA, M. (2002). MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2: 289-300.
48. HOLMGREN, L., O'REILLY, M.S. and FOLKMAN, J. (1995). Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153.
49. HORTON, C.E., CRAWFORD, H.H., LOVE, H.G. and LOEFFLER, R.A. (1958). The malignant potential of burn scar. Plast Reconstr Surg Transplant Bull 22: 348-353.
50. HUSEMANN, Y., GEIGL, J.B., SCHUBERT, F., MUSIANI, P., MEYER, M., BURGHART, E., FORNI, G., EILS, R., FEHM, T., RIETHMULLER, G. et al., (2008). Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68.
51. JEMAL, A., SIEGEL, R., WARD, E., HAO, Y., XU, J., MURRAY, T. and THUN, M.J. (2008). Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
52. JEMAL, A., SIEGEL, R., XU, J. and WARD, E. (2010). Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
53. JOYCE, J.A. and POLLARD, J.W. (2009). Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252.
54. KALLURI, R. and ZEISBERG, M. (2006). Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
55. KANG, Y., SIEGEL, P.M., SHU, W., DROBNJAK, M., KAKONEN, S.M., CORDON-CARDO, C., GUISE, T.A. and MASSAGUE, J. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
56. KAPLAN, R.N., RIBA, R.D., ZACHAROULIS, S., BRAMLEY, A.H., VINCENT, L., COSTA, C., MACDONALD, D.D., JIN, D.K., SHIDO, K., KERNS, S.A. et al., (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
57. KIM, M.Y., OSKARSSON, T., ACHARYYA, S., NGUYEN, D.X., ZHANG, X.H., NORTON, L. and MASSAGUE, J. (2009). Tumor self-seeding by circulating cancer cells. Cell 139: 1315-1326.
58. KLEIN, C.A. (2009). Parallel progression of primary tumours and metastases. Nat Rev Cancer 9: 302-312.
59. KOTZEN, R.M., SWANSON, R.M., MILHORAT, T.H. and BOOCKVAR, J.A. (1999). Post-traumatic meningioma: case report and historical perspective. J Neurol Neurosurg Psychiatry 66: 796-798.
60. KUMAR, R., FOSSATI, V., ISRAEL, M. and SNOECK, H.W. (2008). Lin-Sca1+kit-bone marrow cells contain early lymphoid-committed precursors that are distinct from common lymphoid progenitors. J Immunol 181: 7507-7513.
61. LIN, E.Y. and POLLARD, J.W. (2007). Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67: 5064-5066.
62. LIU, M. and HICKLIN, D. (2011). Human Tumor Xenograft Efficacy Models. In Tumor Models in Cancer Research, (ed. TEICHER, B. A.). Springer Science+Business Media, New York, pp. 99-124.
63. LUZZI, K.J., MACDONALD, I.C., SCHMIDT, E.E., KERKVLIET, N., MORRIS, V.L., CHAMBERS, A.F. and GROOM, A.C. (1998). Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153: 865-873.
64. MARTIN, D.N., BOERSMA, B.J., YI, M., REIMERS, M., HOWE, T.M., YFANTIS, H.G., TSAI, Y.C., WILLIAMS, E.H., LEE, D.H., STEPHENS, R.M. et al., (2009). Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One 4: e4531.
65. MCALLISTER, S.S., GIFFORD, A.M., GREINER, A.L., KELLEHER, S.P., SAELZLER, M.P., INCE, T.A., REINHARDT, F., HARRIS, L.N., HYLANDER, B.L., REPASKY, E.A. et al., (2008). Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133: 994-1005.
66. MCALLISTER, S.S. and WEINBERG, R.A. (2010). Tumor-host interactions: a far-reaching relationship. J Clin Oncol 28: 4022-4028.
67. MINN, A.J., GUPTA, G.P., SIEGEL, P.M., BOS, P.D., SHU, W., GIRI, D.D., VIALE, A., OLSHEN, A.B., GERALD, W.L. and MASSAGUE, J. (2005). Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
68. MIYAZAKI, K., OKADA, Y., YAMANAKA, O., KITANO, A., IKEDA, K., KON, S., UEDE, T., RITTLING, S.R., DENHARDT, D.T., KAO, W.W. et al., (2008). Corneal wound healing in an osteopontin-deficient mouse. Invest Ophthalmol Vis Sci 49: 1367-1375.
69. MOMBAERTS, P., IACOMINI, J., JOHNSON, R.S., HERRUP, K., TONEGAWA, S. and PAPAIOANNOU, V.E. (1992). RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
70. MOORE, M.A., HATTORI, K., HEISSIG, B., SHIEH, J.H., DIAS, S., CRYSTAL, R.G. and RAFII, S. (2001). Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci 938: 36-45; discussion 45-47.
71. MOR, G., VISINTIN, I., LAI, Y., ZHAO, H., SCHWARTZ, P., RUTHERFORD, T., YUE, L., BRAY-WARD, P. and WARD, D.C. (2005). Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci USA 102: 7677-7682.
72. MORI, R., SHAW, T.J. and MARTIN, P. (2008). Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 205: 43-51.
73. MORIHARA, K., TAKENAKA, H., MORIHARA, T. and KISHIMOTO, S. (2007). Primary cutaneous anaplastic large cell lymphoma associated with vascular endothelial growth factor arising from a burn scar. J Am Acad Dermatol 57: S103-S105.
74. MULLEN, C.A., URBAN, J.L., VAN WAES, C., ROWLEY, D.A. and SCHREIBER, H. (1985). Multiple cancers. Tumor burden permits the outgrowth of other cancers. J Exp Med 162: 1665-1682.
75. MURTHY, S.M., GOLDSCHMIDT, R.A., RAO, L.N., AMMIRATI, M., BUCHMANN, T. and SCANLON, E.F. (1989). The influence of surgical trauma on experimental metastasis. Cancer 64: 2035-2044.
76. NAGRATH, S., SEQUIST, L.V., MAHESWARAN, S., BELL, D.W., IRIMIA, D., ULKUS, L., SMITH, M.R., KWAK, E.L., DIGUMARTHY, S., MUZIKANSKY, A. et al., (2007). Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239.
77. NAUMOV, G.N., BENDER, E., ZURAKOWSKI, D., KANG, S.Y., SAMPSON, D., FLYNN, E., WATNICK, R.S., STRAUME, O., AKSLEN, L.A., FOLKMAN, J. et al., (2006). A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst 98: 316-325.
78. NAVIN, N., KENDALL, J., TROGE, J., ANDREWS, P., RODGERS, L., MCINDOO, J., COOK, K., STEPANSKY, A., LEVY, D., ESPOSITO, D. et al., (2011). Tumour evolution inferred by single-cell sequencing. Nature 472: 90-94.
79. NIELSEN, M., THOMSEN, J.L., PRIMDAHL, S., DYREBORG, U. and ANDERSEN, J.A. (1987). Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 56: 814-819.
80. NOWELL, P.C. (1976). The clonal evolution of tumor cell populations. Science 194: 23-28.
81. O'REILLY, M.S., BOEHM, T., SHING, Y., FUKAI, N., VASIOS, G., LANE, W.S., FLYNN, E., BIRKHEAD, J.R., OLSEN, B.R. and FOLKMAN, J. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285.
82. O'REILLY, M.S., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R.A., MOSES, M., LANE, W.S., CAO, Y., SAGE, E.H. and FOLKMAN, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328.
83. OKAMOTO, N., MORIO, S., INOUE, R. and AKIYAMA, K. (1987). The risk of a second primary cancer occurring in five-year survivors of an initial cancer. Jpn J Clin Oncol 17: 205-213.
84. OOSTERLING, S.J., VAN DER BIJ, G.J., VAN EGMOND, M. and VAN DER SIJP, J.R. (2005). Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol 31: 29-37.
85. ORIMO, A., GUPTA, P.B., SGROI, D.C., ARENZANA-SEISDEDOS, F., DELAUNAY, T., NAEEM, R., CAREY, V.J., RICHARDSON, A.L. and WEINBERG, R.A. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
86. PANET-RAYMOND, V., TRUONG, P.T., ALEXANDER, C., LESPERANCE, M., MCDONALD, R.E. and WATSON, P.H. (2011a). Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence. Cancer 117: 2035-2043.
87. PANET-RAYMOND, V., TRUONG, P.T., MCDONALD, R.E., ALEXANDER, C., ROSS, L., RYHORCHUK, A. and WATSON, P.H. (2011b). True Recurrence versus New Primary: An Analysis of Ipsilateral Breast Tumor Recurrences After Breast-Conserving Therapy. Int J Radiat Oncol Biol Phys. 81: 409-417.
88. PANTEL, K., BRAKENHOFF, R.H. and BRANDT, B. (2008). Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8: 329-340.
89. PANTEL, K., COTE, R.J. and FODSTAD, O. (1999). Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91: 1113-1124.
90. PANTELEAKOU, Z., LEMBESSIS, P., SOURLA, A., PISSIMISSIS, N., POLYZOS, A., DELIVELIOTIS, C. and KOUTSILIERIS, M. (2009). Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance. Mol Med 15: 101-114.
91. PAZOLLI, E., LUO, X., BREHM, S., CARBERY, K., CHUNG, J.J., PRIOR, J.L., DOHERTY, J., DEMEHRI, S., SALAVAGGIONE, L., PIWNICA-WORMS, D. et al., (2009). Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res 69: 1230-1239.
92. QUINTANA, E., SHACKLETON, M., FOSTER, H.R., FULLEN, D.R., SABEL, M.S., JOHNSON, T.M. and MORRISON, S.J. (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18: 510-523.
93. RAFII, S. (2000). Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 105: 17-19.
94. RANDALL, T.D. and WEISSMAN, I.L. (1998). Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population? Stem Cells 16: 38-48.
95. RETSKY, M.W., DEMICHELI, R., HRUSHESKY, W.J., BAUM, M. and GUKAS, I.D. (2008). Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS 116: 730-741.
96. ROMANOV, S.R., KOZAKIEWICZ, B.K., HOLST, C.R., STAMPFER, M.R., HAUPT, L.M. and TLSTY, T.D. (2001). Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409: 633-637.
97. RONNOV-JESSEN, L., PETERSEN, O.W. and BISSELL, M.J. (1996). Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76: 69-125.
98. RUDLAND, P.S., PLATT-HIGGINS, A., EL-TANANI, M., DE SILVA RUDLAND, S., BARRACLOUGH, R., WINSTANLEY, J.H., HOWITT, R. and WEST, C.R. (2002). Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 62: 3417-3427.
99. RUITERKAMP, J., ERNST, M.F., VAN DE POLL-FRANSE, L.V., BOSSCHA, K., TJAN-HEIJNEN, V.C. and VOOGD, A.C. (2009). Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol 35: 1146-1151.
100. RUITERKAMP, J., VOOGD, A.C., BOSSCHA, K., TJAN-HEIJNEN, V.C. and ERNST, M.F. (2010). Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature. Breast Cancer Res Treat 120: 9-16.
101. SAKR, W.A., GRIGNON, D.J., HAAS, G.P., SCHOMER, K.L., HEILBRUN, L.K., CASSIN, B.J., POWELL, J., MONTIE, J.A., PONTES, J.E. and CRISSMAN, J.D. (1995). Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol Res Pract 191: 838-841.
102. SANCHEZ-CHAPADO, M., OLMEDILLA, G., CABEZA, M., DONAT, E. and RUIZ, A. (2003). Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate 54: 238-247.
103. SCHAAPVELD, M., VISSER, O., LOUWMAN, M.J., DE VRIES, E.G., WILLEMSE, P.H., OTTER, R., VAN DER GRAAF, W.T., COEBERGH, J.W. and VAN LEEUWEN, F.E. (2008). Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol 26: 1239-1246.
104. SHIAO, S.L. and COUSSENS, L.M. (2010). The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplasia 15: 411-421.
105. SHIBUE, T. and WEINBERG, R.A. (2009). Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106: 10290-10295.
106. SIEWEKE, M.H., THOMPSON, N.L., SPORN, M.B. and BISSELL, M.J. (1990). Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science 248: 1656-1660.
107. SWENERTON, K.D., LEGHA, S.S., SMITH, T., HORTOBAGYI, G.N., GEHAN, E.A., YAP, H.Y., GUTTERMAN, J.U. and BLUMENSCHEIN, G.R. (1979). Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39: 1552-1562.
108. TLSTY, T.D. and COUSSENS, L.M. (2006). Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150.
109. TOMIAK, E., PICCART, M., MIGNOLET, F., SAHMOUD, T., PARIDAENS, R., NOOY, M., BEEX, L., FENTIMAN, I.S., MULLER, A., VAN DER SCHUEREN, E. et al., (1996). Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study. Eur J Cancer 32A: 1876-1887.
110. TROWBRIDGE, J.J., GUEZGUEZ, B., MOON, R.T. and BHATIA, M. (2010). Wnt3a activates dormant c-Kit(-) bone marrow-derived cells with short-term multilineage hematopoietic reconstitution capacity. Stem Cells 28: 1379-1389.
111. TUCK, A.B., CHAMBERS, A.F. and ALLAN, A.L. (2007). Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. J Cell Biochem 102: 859-868.
112. WALKER, R.A. (2001). The complexities of breast cancer desmoplasia. Breast Cancer Res 3: 143-145.
113. WALLACE, J.A., LI, F., LEONE, G. and OSTROWSKI, M.C. (2011). Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. Cancer Res 71: 1203-1207.
114. WILLIS, R.A. (1934). The Spread of Tumors in the Human Body. J. & A. Churchill, London.
115. WITHERS, H.R. and LEE, S.P. (2006). Modeling growth kinetics and statistical distribution of oligometastases. Semin Radiat Oncol 16: 111-119.
116. WYCKOFF, J., WANG, W., LIN, E.Y., WANG, Y., PIXLEY, F., STANLEY, E.R., GRAF, T., POLLARD, J.W., SEGALL, J. and CONDEELIS, J. (2004). A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022-7029.
117. XIAO, S., SU, D.M. and MANLEY, N.R. (2008). T cell development from kit-negative progenitors in the Foxn1Delta/Delta mutant thymus. J Immunol 180: 914-921.